Huy P. Pham

Huy P. Pham

Auto-generated profile, based on publicly available information

Huy P. Pham

Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2023 in Journal of Clinical Apheresis
Verified
Journal Article
Closed access
LCLaura S Connelly-Smith
Laura S Connelly-Smith
CACaroline R. Alquist
Caroline R. Alquist
NANicole A. Aqui
Nicole A. Aqui
JHJan C. Hofmann
Jan C. Hofmann
RKReinhard Klingel
Reinhard Klingel
NDNancy M. Dunbar
Nancy M. Dunbar

1 December 2013 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
HPH. P. Pham
H. P. Pham
BSB. H. Shaz
B. H. Shaz
Massive haemorrhage requires massive transfusion (MT) to maintain adequate circulation and haemostasis. For optimal management of massively bleeding patients, regardless of aetiology (trauma, obstetrical, surgical), effective preparation and communication between transfusion and other laboratory services and clinical teams are essential. A well-defined MT protocol is a valuable tool to delineate how blood products are ordered, prepared, and delivered; determine laboratory algorithms to use as transfusion guidelines; and outline duties and facilitate communication between involved personnel. In MT patients, it is crucial to practice damage control resuscitation and to administer blood products early in the resuscitation. Trauma patients are often admitted with early trauma-induced coagulopathy (ETIC), which is associated with mortality; the aetiology of ETIC is likely multifactorial. Current data support that trauma patients treated with higher ratios of plasma and platelet to red blood cell transfusions have improved outcomes, but further clinical investigation is needed. Additionally, tranexamic acid has been shown to decrease the mortality in trauma patients requiring MT. Greater use of cryoprecipitate or fibrinogen concentrate might be beneficial in MT patients from obstetrical causes. The risks and benefits for other therapies (prothrombin complex concentrate, recombinant activated factor VII, or whole blood) are not clearly defined in MT patients. Throughout the resuscitation, the patient should be closely monitored and both metabolic and coagulation abnormalities corrected. Further studies are needed to clarify the optimal ratios of blood products, treatment based on underlying clinical disorder, use of alternative therapies, and integration of laboratory testing results in the management of massively bleeding patients.

2 July 2013 in Vox Sanguinis
Verified
Journal Article
Open access
PDF file
RFR. O. Francis
R. O. Francis
JJJ. S. Jhang
J. S. Jhang
HPH. P. Pham
H. P. Pham
EHE. A. Hod
E. A. Hod
JZJ. C. Zimring
J. C. Zimring
SSSteven Leonard Spitalnik
Steven Leonard Spitalnik
The hallmark of glucose‐6‐phosphate dehydrogenase (G6PD) deficiency is red blood cell (RBC) destruction in response to oxidative stress. Patients requiring RBC transfusions may simultaneously receive oxidative medications or have concurrent infections, both of which can induce haemolysis in G6PD‐deficient RBCs. Although it is not routine practice to screen healthy blood donors for G6PD deficiency, case reports identified transfusion of G6PD‐deficient RBCs as causing haemolysis and other adverse events. In addition, some patient populations may be more at risk for complications associated with transfusions of G6PD‐deficient RBCs because they receive RBCs from donors who are more likely to have G6PD deficiency. This review discusses G6PD deficiency, its importance in transfusion medicine, changes in the RBC antioxidant system (of which G6PD is essential) during refrigerated storage and mechanisms of haemolysis. In addition, as yet unanswered questions that could be addressed by translational and clinical studies are identified and discussed.

1 June 2016 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
COC. K. Okerberg
C. K. Okerberg
LWL. A. Williams
L. A. Williams
MKM. L. Kilgore
M. L. Kilgore
CKC. H. Kim
C. H. Kim
MMM. B. Marques
M. B. Marques
HPH. P. Pham
H. P. Pham

5 September 2011 in Journal of Clinical Apheresis
Verified
Journal Article
Closed access
PDF file
HPHuy P. Pham
Huy P. Pham
JDJennifer A. Daniel‐Johnson
Jennifer A. Daniel‐Johnson
BSBrie A. Stotler
Brie A. Stotler
HSHannah Stephens
Hannah Stephens
JSJoseph Schwartz
Joseph Schwartz

14 August 2015 in Journal of Clinical Apheresis
Verified
Journal Article
Closed access
PDF file
HPHuy P. Pham
Huy P. Pham
JSJoseph Schwartz
Joseph Schwartz
LCLaura Cooling
Laura Cooling
JHJan C. Hofmann
Jan C. Hofmann
HKHaewon C. Kim
Haewon C. Kim
YWYanyun Wu
Yanyun Wu